<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In previous studies, we showed that basic fibroblast growth factor (bFGF) reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volume when infused intravenously in animal models of focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In the current study, we examined the potential mechanism of <z:mpath ids='MPATH_124'>infarct</z:mpath> reduction by bFGF, especially effects on <z:mpath ids='MPATH_3'>apoptosis</z:mpath> within the ischemic brain </plain></SENT>
<SENT sid="2" pm="."><plain>We found that bFGF decreased DNA fragmentation in the ischemic hemisphere, as assessed by terminal deoxynucleotidyl transferase (TdT)-mediated <z:chebi fb="0" ids="17625">dUTP</z:chebi>-<z:chebi fb="1" ids="15956">biotin</z:chebi> nick end labeling (TUNEL) histochemical methods combined with morphological criteria </plain></SENT>
<SENT sid="3" pm="."><plain>bFGF also prevented reduction of immunoreactivity of the anti-apoptotic protein Bcl-2 in the ischemic hemisphere, but did not alter immunoreactivity of the pro-apoptotic proteins Bax, Caspase-1, or Caspase-3 </plain></SENT>
<SENT sid="4" pm="."><plain>These changes in TUNEL histochemistry and Bcl-2 immunoreactivity were especially prominent in cortex at the borders ('penumbra') of <z:mpath ids='MPATH_124'>infarcts</z:mpath>, spared by bFGF treatment </plain></SENT>
<SENT sid="5" pm="."><plain>We conclude that the <z:mpath ids='MPATH_124'>infarct</z:mpath>-reducing effects of bFGF may be due, in part, to prevention of downregulation of Bcl-2 expression and <z:mp ids='MP_0006043'>decreased apoptosis</z:mp> in the ischemic brain </plain></SENT>
</text></document>